BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29759329)

  • 21. Single or multi-channel vaginal cuff high-dose-rate brachytherapy: Is replanning necessary prior to each fraction?
    Zhou J; Prisciandaro J; Lee C; Schipper M; Eisbruch A; Jolly S
    Pract Radiat Oncol; 2014; 4(1):20-6. PubMed ID: 24621419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric comparison of multichannel with one single-channel vaginal cylinder for vaginal cancer treatments with high-dose-rate brachytherapy.
    Kim H; Rajagopalan MS; Houser C; Beriwal S
    Brachytherapy; 2014; 13(3):263-7. PubMed ID: 24080298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic analysis of high-dose-rate (192)Ir vaginal cuff brachytherapy for endometrial cancer using a cylindrical target volume model and varied cancer cell distributions.
    Zhang H; Donnelly ED; Strauss JB; Qi Y
    Med Phys; 2016 Jan; 43(1):483. PubMed ID: 26745941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Dosimetric evaluation of a high dose rate cobalt-60 brachytherapy source using shielded, single and multi-channel cylinder applicators for gynecological cancers.
    Abtahi M; Safaei AM; Sheikhzade P; Gholami S
    Med Dosim; 2022 Winter; 47(4):318-324. PubMed ID: 35907692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
    Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
    Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.
    Harkenrider MM; Block AM; Alektiar KM; Gaffney DK; Jones E; Klopp A; Viswanathan AN; Small W
    Brachytherapy; 2017; 16(1):95-108. PubMed ID: 27260082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I-II endometrial cancer: A monoinstitutional experience.
    Perrucci E; Lancellotta V; Bini V; Zucchetti C; Mariucci C; Montesi G; Saccia S; Palumbo I; Aristei C
    Brachytherapy; 2016; 15(2):177-84. PubMed ID: 26727332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?
    Patel S; Mehta KJ; Kuo HC; Ohri N; Patel R; Yaparpalvi R; Garg MK; Guha C; Kalnicki S
    Brachytherapy; 2016; 15(2):185-90. PubMed ID: 26796601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society.
    Harkenrider MM; Grover S; Erickson BA; Viswanathan AN; Small C; Kliethermes S; Small W
    Brachytherapy; 2016; 15(1):23-9. PubMed ID: 26620818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prescription depth, cylinder size, treatment length, tip space, and curved end on doses in high-dose-rate vaginal brachytherapy.
    Li S; Aref I; Walker E; Movsas B
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1268-77. PubMed ID: 17336226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an indigenous low-cost multichannel cylinder applicator for vaginal tumors.
    Bajwa HK; Singareddy R; Talluri AK; Guntupalli R; Raju AK; Sresty M; Ahmed A
    Brachytherapy; 2020; 19(5):674-678. PubMed ID: 32540330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multichannel vaginal cylinder brachytherapy-Impact of tumor thickness and location on dose to organs at risk.
    Glaser SM; Kim H; Beriwal S
    Brachytherapy; 2015; 14(6):913-8. PubMed ID: 26412618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric comparison of optimization methods for multichannel intracavitary brachytherapy for superficial vaginal tumors.
    Lapuz C; Dempsey C; Capp A; O'Brien PC
    Brachytherapy; 2013; 12(6):637-44. PubMed ID: 23850274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-Dose Adjuvant Cylinder Brachytherapy for Endometrioid Endometrial Cancer.
    Alban GM; Buscariollo DL; Cheng T; Pretz J; Krechmer B; Buzurovic I; Singer L; King M; Lee L
    Pract Radiat Oncol; 2020; 10(2):95-103. PubMed ID: 31783169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
    Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
    Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer.
    Vargo JA; Kim H; Houser CJ; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
    Brachytherapy; 2015; 14(1):9-15. PubMed ID: 25456026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do air gaps with image-guided vaginal cuff brachytherapy impact failure rates in patients with high-intermediate risk FIGO Stage I endometrial cancer?
    Richman AH; Patel AK; Rodríguez-López JL; Keller A; Vargo JA; Kim H; Sukumvanich P; Berger JL; Boisen MM; Edwards R; Taylor SE; Courtney-Brooks MB; Olawaiye A; Orr BC; Lesnock JL; Beriwal S
    Brachytherapy; 2021; 20(3):512-518. PubMed ID: 33384254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
    Beriwal S; Kim H; Heron DE; Selvaraj R
    Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose accumulation during vaginal cuff brachytherapy based on rigid/deformable registration vs. single plan addition.
    Sabater S; Andres I; Sevillano M; Berenguer R; Machin-Hamalainen S; Arenas M
    Brachytherapy; 2014; 13(4):343-51. PubMed ID: 24388615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.